CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...